Bertrand Georges
Technik-/Wissenschafts-/F&E-Leiter bei ALTIMMUNE, INC.
Aktive Positionen von Bertrand Georges
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALTIMMUNE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2015 | - |
Karriereverlauf von Bertrand Georges
Ehemalige bekannte Positionen von Bertrand Georges
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.03.2015 |
| Gründer | 05.10.1992 | 01.03.2015 | |
Sedac Therapeutics SA
 Sedac Therapeutics SA Medical/Nursing ServicesHealth Services Sedac Therapeutics SA develops new peptide formulas synthetic products in the fields of diagnosis and vaccine immunotherapy. The company is headquartered in Lyon, France. | Corporate Officer/Principal | 01.01.1999 | 01.01.2003 |
Ausbildung von Bertrand Georges
| Pasteur Institute of Iran | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 2 |
| Vereinigte Staaten | 2 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALTIMMUNE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Sedac Therapeutics SA
Sedac Therapeutics SA Medical/Nursing ServicesHealth Services Sedac Therapeutics SA develops new peptide formulas synthetic products in the fields of diagnosis and vaccine immunotherapy. The company is headquartered in Lyon, France. | Health Services |
- Börse
- Insiders
- Bertrand Georges
- Erfahrung
